Progress in the treatment of rheumatoid arthritis

JAMA. 2001 Dec 12;286(22):2787-90. doi: 10.1001/jama.286.22.2787.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Analgesics / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Etanercept
  • Glucocorticoids / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Methotrexate / therapeutic use
  • Minocycline / therapeutic use
  • Penicillamine / therapeutic use
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Sulfasalazine / therapeutic use

Substances

  • Analgesics
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Glucocorticoids
  • Immunoglobulin G
  • Isoxazoles
  • Receptors, Tumor Necrosis Factor
  • Sulfasalazine
  • Hydroxychloroquine
  • Cyclosporine
  • Infliximab
  • Minocycline
  • Leflunomide
  • Penicillamine
  • Azathioprine
  • Etanercept
  • Methotrexate